Sumitomo Pharma Raises FY2026 Net Profit Forecast to JPY 94 Billion

Bitget2026/10/30 06:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sumitomo Pharma raised its FY2026 net profit forecast to JPY 94 billion from JPY 77 billion on October 30, 2026.
Core operating profit guidance increased to JPY 105 billion from JPY 91 billion.
Revenue is now forecast at JPY 565 billion, versus JPY 540 billion, supported by stronger U.S. sales and European demand.
GEMTESA sales guidance rose to USD 752 million from USD 686 million, reflecting favorable first-half pricing.
A year-end dividend of JPY 15 per share is planned, reinstating payouts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Pharma Co. Ltd. published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sumitomo Pharma Raises FY2026 Net Profit Forecast to JPY 94 Billion

You may also like

Crypto prices